Patents by Inventor Nigel John Osborn

Nigel John Osborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10134496
    Abstract: Methods and devices for directing a waste fluid from a radiopharmaceutical synthesis system to a waste vessel are provided. In one example, the method includes serially connecting a primary waste vessel to a secondary waste vessel with a fluid conduit, including a waste valve connected to the fluid conduit extending between the primary waste vessel and secondary waste vessel; opening the waste valve so as to allow fluid communication between cavities of the primary and secondary waste vessels; drawing a low pressure in both waste vessels; closing the waste valve so as to fluidically isolate the secondary waste vessel from the primary waste vessel, discharging the waste fluid through a pump valve into the primary waste vessel, and opening the waste valve to evacuate the waste fluid from the primary waste vessel into the secondary waste vessel.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: November 20, 2018
    Assignee: GE Healthcare Limited Company
    Inventors: Nigel John Osborn, Julian Grigg, Eric Horn, Jonathan Robert Shales
  • Patent number: 10000518
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-ß-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: June 19, 2018
    Assignees: GE HEALTHCARE LIMITED, GE HEALTHCARE AS
    Inventors: Lill Torild Wickstrom, Dirk-Jan in't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Patent number: 9969761
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: May 15, 2018
    Assignees: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: Torild Wickstrom, Dirk-Jan In't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Publication number: 20160314866
    Abstract: The present invention relates to methods and devices for evacuating the contents of a primary waste vessel to a secondary waste vessel, desirably between production runs of an automated synthesis device.
    Type: Application
    Filed: December 19, 2014
    Publication date: October 27, 2016
    Inventors: Nigel John Osborn, Julian Grigg, Eric Horn, Jonathan Robert Shales
  • Publication number: 20150018541
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Application
    Filed: April 22, 2014
    Publication date: January 15, 2015
    Applicants: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: Torild WICKSTROM, DIRK-JAN IN'T VELD, NIGEL JOHN OSBORN, JULIAN GRIGG, ANTHONY WILSON
  • Patent number: 8053622
    Abstract: The invention describes a method for stripping alumina which is particularly suitable for removal of fluoride from alumina and comprises washing said alumina with an aqueous acid or alkali at elevated temperature. The method may be used for removal of unreacted radiofluoride such as [18F]fluoride from alumina following a radiofluorination reaction. Automated synthesis apparatus and cassettes therefor, which are adapted to perform the method are also claimed.
    Type: Grant
    Filed: March 21, 2006
    Date of Patent: November 8, 2011
    Assignee: GE Healthcare Limited
    Inventors: Nigel John Osborn, Julian Grigg
  • Publication number: 20100029930
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Application
    Filed: November 18, 2005
    Publication date: February 4, 2010
    Inventors: Lill Torild Wickstrom, Dirk-Jan in't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Publication number: 20090076259
    Abstract: The invention relates to an improved process for the fluoridation of sugar derivatives in which a controlled amount of water is present in the solvent.
    Type: Application
    Filed: November 18, 2005
    Publication date: March 19, 2009
    Inventors: Nigel John Osborn, Julian Grigg, Roger Paul Pettitt, Anthony Wilson, Nigel Anthony Powell
  • Publication number: 20080305042
    Abstract: The present invention provides a method for the preparation of radioisotopically-labelled imaging agent compositions. The method uses precursors which are bound to soluble polymers, so that the radiolabelling reaction is carried out in solution. Also described are radiopharmaceutical compositions, automated versions of the radiolabelling method and disposable cassettes for use in the automated method.
    Type: Application
    Filed: December 5, 2006
    Publication date: December 11, 2008
    Inventors: Michel Gacek, Hanno Priebe, Nigel John Osborn
  • Publication number: 20080226543
    Abstract: The invention describes a method for stripping alumina which is particularly suitable for removal of fluoride from alumina and comprises washing said alumina with an aqueous acid or alkali at elevated temperature. The method may be used for removal of unreacted radiofluoride such as [18F]fluoride from alumina following a radiofluorination reaction. Automated synthesis apparatus and cassettes therefor, which are adapted to perform the method are also claimed.
    Type: Application
    Filed: March 21, 2006
    Publication date: September 18, 2008
    Inventors: Nigel John Osborn, Julian Grigg
  • Publication number: 20040242854
    Abstract: Disclosed is a capture reagent having Formula I:
    Type: Application
    Filed: July 16, 2004
    Publication date: December 2, 2004
    Inventors: Nigel John Osborn, Karen Williams, Alison Claire Sweet